Australia markets close in 3 hours 19 minutes

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.56-0.66 (-1.53%)
At close: 04:00PM EDT
42.56 0.00 (0.00%)
After hours: 07:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-417,273
-528,628
-652,172
-746,354
-344,874
-
Depreciation & amortisation
1,633
1,704
1,487
1,492
859
-
Stock-based compensation
107,471
105,945
91,085
70,667
45,376
-
Change in working capital
-267,759
-200,169
-15,698
-93,522
19,586
-
Accounts receivable
-236,352
-198,715
2,375
-10,103
0
-
Inventory
-75,712
-60,647
-69,397
-16,317
0
-
Accounts payable
-4,706
170
18,689
10,487
-54
-
Other working capital
-550,905
-595,508
-515,269
-564,229
-165,910
-
Other non-cash items
25,729
26,293
28,663
6,327
15,536
-
Net cash provided by operating activities
-550,098
-594,735
-513,745
-563,126
-160,488
-
Cash flows from investing activities
Investments in property, plant and equipment
-807
-773
-1,524
-1,103
-5,422
-
Purchases of investments
-
0
-331,863
-171,281
-879,067
-
Sales/maturities of investments
-
0
393,280
420,000
567,500
-
Net cash used for investing activities
-708
-674
59,893
247,616
-316,989
-
Cash flows from financing activities
Debt repayment
-
-
-
0
0
-28,701
Common stock issued
98,763
384,387
380,120
380,363
381,423
-
Other financing activities
-55,569
-66,540
-40,182
-5,788
-23,112
-
Net cash used provided by (used for) financing activities
111,605
394,499
365,659
392,236
692,178
-
Net change in cash
-439,331
-200,775
-88,681
74,710
215,060
-
Cash at beginning of period
766,358
553,074
641,755
567,045
351,985
-
Cash at end of period
327,157
352,299
553,074
641,755
567,045
-
Free cash flow
Operating cash flow
-550,098
-594,735
-513,745
-563,126
-160,488
-
Capital expenditure
-807
-773
-1,524
-1,103
-5,422
-
Free cash flow
-550,905
-595,508
-515,269
-564,229
-165,910
-